Antimicrobial-associated harm in critical care: a narrative review
Open accessThe DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
The belief that, for the individual patient, the benefit of prompt and continued use of antimicrobials outweighs any potential harm is a significant barrier to improved stewardship of these vital agents. Antimicrobial stewardship may be perceived as utilitarian rationing, seeking to preserve the availability of effective antimicrobials by limiting the development of resistance in a manner which could conflict with the immediate treatment of the patient in need. This view does not account for the growing evidence of antimicrobial-associated harm to individual patients. This review sets out the evidence for antimicrobial-associated harm and how this should be balanced with the need for prompt and appropriate therapy in infection. It describes the mechanisms by which antimicrobials may harm patients including: mitochondrial toxicity; immune cell toxicity; adverse drug reactions; selection of resistant organisms within a given patient; and disruption of the microbiome. Finally, the article indicates how the harms of antimicrobials may be mitigated and identifies areas for research and development in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Unnecessary antibiotic use increases the risk of developing multidrug-resistant organisms and leading to serious side effects and complications, including C. difficile infection, allergic reactions, and organ toxicity [22].”
From Clinical utility of a cerebrospinal fluid multiplex PCR meningitis/encephalitis panel in children: a retrospective review of positive results (2026) · cites this paper as [22]
In the citing paper
“The desirable effects of empiric antiviral therapy are unknown, and as for other antimicrobial agents there is a risk of undesirable effects [165].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [165]
In the citing paper
“while in patients with a low risk for MDR organisms, we suggest using a single agents for empiric treatment, as there are no apparent benefits of using two agents and the a risk of antimicrobial-associated undesirable effects, including direct toxicity, Clostridioides difficile infection and development of antibiotic resistance [165].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [165]
In the citing paper
“Antimicrobial exposure is linked to the development of antimicrobial resistance and efforts to reduce both the number of antibiotics administered and their spectrum of therapy are therefore important strategies in patients with sepsis and septic shock [165].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [165]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Time to treatment and mortality during mandated emergency care for sepsis.
Seymour, C. W., Gesten, F., Prescott, H. C., Friedrich, M. E., Iwashyna, T. J., Phillips, G. S., Lemeshow, S., Osborn, T., Terry, K. M., & Levy, M. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703058 · Cited by 2,225
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens
Santajit, S., & Indrawattana, N. (2016) · BioMed Research International · doi:10.1155/2016/2475067 · Cited by 1,641
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627
Chiu, C. Y., & Miller, S. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0113-7 · Cited by 1,620
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Ventilator-associated pneumonia in critically ill patients with COVID-19
Maes, M., Higginson, E., Pereira-Dias, J., Curran, M. D., Parmar, S., Khokhar, F., Cuchet-Lourenço, D., Lux, J., Sharma-Hajela, S., Ravenhill, B., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03460-5 · Cited by 312
Wang, B., Xu, Z., & Dong, B. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.133925 · Cited by 239
Fernando, S. M., Tran, A., Cheng, W., Klompas, M., Kyeremanteng, K., Mehta, S., English, S. W., Muscedere, J., Cook, D. J., Torres, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06036-z · Cited by 231
Sepsis-associated encephalopathy and septic encephalitis: an update
Tauber, S. C., Djukic, M., Gossner, J., Eiffert, H., Brück, W., & Nau, R. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1812384 · Cited by 228
Initial antimicrobial management of sepsis
Niederman, M. S., Baron, R. M., Bouadma, L., Calandra, T., Daneman, N., DeWaele, J., Kollef, M. H., Lipman, J., & Nair, G. B. (2021) · Critical Care · doi:10.1186/s13054-021-03736-w · Cited by 180
Self-citationPulmonary infections complicating ARDS
Luyt, C.-E., Bouadma, L., Morris, A. C., Dhanani, J. A., Kollef, M., Lipman, J., Martin-Loeches, I., Nseir, S., Ranzani, O. T., Roquilly, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06292-z · Cited by 164
Self-citationBeta-Lactams Toxicity in the Intensive Care Unit: An Underestimated Collateral Damage?
Roger, C., & Louart, B. (2021) · Microorganisms · doi:10.3390/microorganisms9071505 · Cited by 143
Ohnuma, T., Chihara, S., Costin, B., Treggiari, M. M., Bartz, R. R., Raghunathan, K., & Krishnamoorthy, V. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.49353 · Cited by 150
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 141
ICU-acquired infections in immunocompromised patients
Kreitmann, L., Helms, J., Martín‐Loeches, I., Salluh, J. I., Poulakou, G., Pène, F., & Nseir, S. (2024) · Intensive Care Medicine · doi:10.1007/s00134-023-07295-2 · Cited by 132
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Optimizing Antimicrobial Drug Dosing in Critically Ill Patients
Póvoa, P. M. S. R., Moniz, P., Gonçalves-Pereira, J., & Coelho, L. (2021) · Microorganisms · doi:10.3390/microorganisms9071401 · Cited by 91
The role of the microbiota in the management of intensive care patients
Szychowiak, P., Villageois-Tran, K., Patrier, J., Timsit, J., & Ruppé, É. (2022) · Annals of Intensive Care · doi:10.1186/s13613-021-00976-5 · Cited by 94
Shappell, C. N., Klompas, M., Ochoa, A., & Rhee, C. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005090 · Cited by 68
Barbier, F., Hraiech, S., Kernéis, S., Veluppillai, N., Pajot, O., Poissy, J., Roux, D., & Zahar, J. (2023) · Annals of Intensive Care · doi:10.1186/s13613-023-01153-6 · Cited by 74
Biomarker‐Guided Individualization of Antibiotic Therapy
Aulin, L. B. S., de Lange, D. W., Saleh, M. A. A., van der Graaf, P. H., Völler, S., & van Hasselt, J. G. C. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2194 · Cited by 76
Lanckohr, C., & Bracht, H. (2022) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000967 · Cited by 75
Pak, T. R., Young, J. G., McKenna, C. S., Agan, A. A., DelloStritto, L. K., Filbin, M. R., Dutta, S., Kadri, S. S., Septimus, E. J., Rhee, C., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad450 · Cited by 64
Singer, M., Angus, D., Annane, D., Bauer, M. W., Kalil, A. C., Klompas, M., Machado, F. R., Martin, G. S., Randolph, A. G., Shankar‐Hari, M., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(25)02422-5 · Cited by 82
Qian, S., Wang, X., Guo, Y., He, W., Yang, J., Chen, H., Li, R., Su, L., Wang, X., Shao, Y., et al. (2025) · Advanced Materials · doi:10.1002/adma.202419209 · Cited by 50
Maina, J. W., Onyambu, F., Kibet, P. S., & Musyoki, A. M. (2023) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-023-00636-5 · Cited by 55
Progress in Multidisciplinary Treatment of Fournier’s Gangrene
Zhang, K.-F., Shi, C.-X., Chen, S.-Y., & Wei, W. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s390008 · Cited by 46
Zhang, J., Yan, W., Dong, Y., Luo, X., Miao, H., Maimaijuma, T., Xu, X., Jiang, H., Huang, Z., Qi, L., et al. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-24-1191 · Cited by 53
Hooper, G. A., Klippel, C., McLean, S. R., Stenehjem, E. A., Webb, B. J., Murnin, E., Hough, C. L., Bledsoe, J. R., Brown, S. M., & Peltan, I. D. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad101 · Cited by 41
Kubo, K., Sakuraya, M., Sugimoto, H., Takahashi, N., Kano, K., Yoshimura, J., Egi, M., & Kondo, Y. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006366 · Cited by 50
Кirov, М. Y., Владимирович, К. В., Николаевич, П. Д., Щеголев, А. В., Babaev, M. A., Belotserkovskiy, B. Z., Bykov, A. O., Gritsan, A. I., Кулабухов, В. В., Kulikov, A. V., et al. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-4-7-42 · Cited by 44
Chen, Q., Zhu, Y., Wang, K., Wang, X., Zhang, Y., Zhou, M., Du, J., Qu, X., Shi, Z., Zhang, Y., et al. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101994 · Cited by 38
Xing, B.-B., Liu, B., Luo, G.-X., Tong, G., Jiao, H., & Xu, L. F. (2023) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.3c03389 · Cited by 33
Jeffrey, M., Denny, K. J., Lipman, J., & Morris, A. C. (2023) · Intensive Care Medicine · doi:10.1007/s00134-023-07108-6 · Cited by 37
Self-citationPredictive modeling of bacterial infections and antibiotic therapy needs in critically ill adults
Eickelberg, G., Sanchez-Pinto, L. N., & Luo, Y. (2020) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2020.103540 · Cited by 36
Qiu, X., Pu, M., Zhang, H., Xu, B., Wang, J., & Xuan, R. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.135656 · Cited by 30
Antibiotic therapy for severe bacterial infections
Timsit, J., Ling, L., de Montmollin, É., Bracht, H., Morris, A. C., Bus, L. D., Falcone, M., Harris, P. N. A., Machado, F. R., Paiva, J.-A., et al. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08063-0 · Cited by 46
Self-citationBruns, N., & Dohna‐Schwake, C. (2021) · Pediatric Research · doi:10.1038/s41390-021-01878-9 · Cited by 37
Gonçalves-Pereira, J., Fernandes, J., Duarte, A. R., & Fernandes, S. M. (2022) · Antibiotics · doi:10.3390/antibiotics11121839 · Cited by 40
Ventriculitis: Infection or Inflammation
Ramanan, M., Shorr, A. F., & Lipman, J. (2021) · Antibiotics · doi:10.3390/antibiotics10101246 · Cited by 40
Self-citationS3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 47
Moniz, P., Coelho, L., & Póvoa, P. M. S. R. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01558-w · Cited by 38
Tabah, A., Lipman, J., Barbier, F., Buetti, N., Timsit, J., & on behalf of the ESCMID Study Group for Infections in Critically Ill Patients—ESGCIP (2022) · Antibiotics · doi:10.3390/antibiotics11030362 · Cited by 39
Self-citationHirano, Y., Shinmoto, K., Okada, Y., Suga, K., Bombard, J., Murahata, S., Shrestha, M., Ocheja, P., & Tanaka, A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.694520 · Cited by 24
Barbier, F., Dupuis, C., Buetti, N., Schwebel, C., Azoulay, É., Argaud, L., Cohen, Y., Ha, V. H. T., Gainnier, M., Siami, S., et al. (2024) · Critical Care · doi:10.1186/s13054-023-04792-0 · Cited by 30
Cerebral Intraparenchymal Hemorrhage Changes Patients’ Gut Bacteria Composition and Function
Xiong, Z., Peng, K., Song, S., Zhu, Y., Gu, J., Huang, C., & Li, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.829491 · Cited by 26
Standard rectal swabs as a surrogate sample for gut microbiome monitoring in intensive care
Schlebusch, S., Graham, R., Jennison, A. V., Lassig‐Smith, M., Harris, P. N. A., Lipman, J., Cuív, P. Ó., & Paterson, D. L. (2022) · BMC Microbiology · doi:10.1186/s12866-022-02487-0 · Cited by 23
Self-citationPractical Lessons on Antimicrobial Therapy for Critically Ill Patients
Cusack, R. A. F., Little, E., & Martín‐Loeches, I. (2024) · Antibiotics · doi:10.3390/antibiotics13020162 · Cited by 27
Wang, J., Pu, Y., Zeng, Y., Chen, Y., Zhao, W. H., Niu, L., Chen, B., Yang, Z., Wu, L., Pan, K., et al. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09881-6 · Cited by 22
Antimicrobial De-Escalation in Critically Ill Patients
Tanzarella, E. S., Cutuli, S. L., Lombardi, G., Cammarota, F., Caroli, A., Franchini, E. O., Sancho, E., Grieco, D. L., Antonelli, M. M., & PASCALE, G. D. (2024) · Antibiotics · doi:10.3390/antibiotics13040375 · Cited by 31
Moragues-Solanas, L., Scotti, R., & O’Grady, J. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1906652 · Cited by 21
Anesthesia Considerations in Infective Endocarditis
Hermanns, H., Eberl, S., Terwindt, L. E., Mastenbroek, T. C. B., Bauer, W. O., van der Vaart, T. W., & Preckel, B. (2022) · Anesthesiology · doi:10.1097/aln.0000000000004130 · Cited by 21
Hsiao, W. W., Selvi, S. V., & Alagumalai, K. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.141474 · Cited by 20
Wu, Y., Sun, A., Chen, F., Zhao, Y., Zhu, X., Zhang, T., Ni, G., & Wang, R. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107293 · Cited by 19
Felice, M. D., Falco, M. D., Serra, A., Frisulli, V., Antonacci, A., Isticato, R., Stefano, L. D., & Scognamiglio, V. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117135 · Cited by 17
Xu, K., Zhang, P., Zhang, P., Zhang, Y., Li, L., Shi, Y., Wen, X., & Xu, Y. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.01.025 · Cited by 16
The Significance and Impact of Screening Preservation Fluid Cultures in Renal Transplant Recipients
Reticker, A., Lichvar, A. B., Walsh, M., Gross, A. E., & Patel, S. (2020) · Progress in Transplantation · doi:10.1177/1526924820978608 · Cited by 16
Soper, N. S., & Albin, O. R. (2023) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2023.62 · Cited by 13
Development and implementation of a customised rapid syndromic diagnostic test for severe pneumonia
Navapurkar, V., Scott, J. B., Maes, M., Hellyer, T. P., Higginson, E. E., Forrest, S., Pereira-Dias, J., Parmar, S., Heasman-Hunt, E., Polgarova, P., et al. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17099.1 · Cited by 16
Self-citationThe Effect of Antibiotics on the Nervous System: Importance for Anesthesiology and Intensive Care
Radkowski, P., Oszytko, J., Sobolewski, K., Trachte, F., Onichimowski, D., & Majewska, M. (2025) · Antibiotics · doi:10.3390/antibiotics14060622 · Cited by 14
Li, S., Li, X., Jiang, S., Wang, C., & Hu, Y. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-01891-x · Cited by 13
Antibiotic-Induced Immunosuppression—A Focus on Cellular Immunity
Snow, T. A. C., Singer, M., & Arulkumaran, N. (2024) · Antibiotics · doi:10.3390/antibiotics13111034 · Cited by 21
Self-citationSulbactam for carbapenem-resistant Acinetobacter baumannii infections: a literature review
Spernovasilis, N. A., Ishak, A., Tsioutis, C., Alon-Ellenbogen, D., Agouridis, A. P., & Mazonakis, N. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf055 · Cited by 12
Development and implementation of a customised rapid syndromic diagnostic test for severe pneumonia
Navapurkar, V., Scott, J. B., Maes, M., Hellyer, T. P., Higginson, E. E., Forrest, S., Pereira-Dias, J., Parmar, S., Heasman-Hunt, E., Polgarova, P., et al. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17099.3 · Cited by 17
Self-citationMolecular Antimicrobial Susceptibility Testing in Sepsis
Martín‐Loeches, I., Gonçalves-Pereira, J., Teoh, T. K., Barlow, G. D., Dortet, L., Carrol, E. D., Olgemöller, U., Boyd, S. E., & Textoris, J. (2024) · Future Microbiology · doi:10.2217/fmb-2023-0128 · Cited by 12
Rueda, F. R., Méndez, R., Suárez-de-la-Rica, A., González, R., & Maseda, E. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14010106 · Cited by 17
Scott, J., Ruchaud‐Sparagano, M., Musgrave, K. M., Roy, A. I., Wright, S. E., Perry, J. D., Morris, A. C., Rostron, A., & Simpson, A. J. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000603 · Cited by 12
Ljungcrantz, E. G., Askman, S., Sjövall, F., & Paulsson, M. (2025) · European Respiratory Review · doi:10.1183/16000617.0229-2024 · Cited by 17
Timing and Spectrum of Antibiotic Treatment for Suspected Sepsis and Septic Shock
Pak, T. R., Rhee, C., & Klompas, M. (2022) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2022.08.001 · Cited by 11
Decalogue for the selection of oral antibiotics for lower respiratory tract infections
Cantón, R., Barberán, J., Linares, M., Molero, J., González-Moro, J. M. R., Salavert, M., & del Castillo, J. M. G. (2022) · Revista Española de Quimioterapia · doi:10.37201/req/172.2021 · Cited by 13
Aerosolized Antibiotic Therapy in Mechanically Ventilated Patients
Ehrmann, S., Barbier, F., & Li, J. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202402-0437cp · Cited by 10
Rademacher, J., Ewig, S., Grabein, B., Nachtigall, I., Abele‐Horn, M., Deja, M., Gaßner, M., Gatermann, S. G., Geffers, C., Gerlach, H., et al. (2025) · Pneumologie · doi:10.1055/a-2541-9872 · Cited by 23
Chen, J., Lin, J., Weng, J., Ju, Y., & Li, Y. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09060-2 · Cited by 9
Current opinion in management of septic shock due to Gram-negative bacteria
Tabah, A., Buetti, N., Barbier, F., & Timsit, J. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000767 · Cited by 11
Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change?
Sopirala, M. M. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000736 · Cited by 8
VAIDYA, R. A., Subbareddy, S., Prasanna, S. B., Selvaraj, M., Assiri, M. A., Chung, R., Mallu, P., Shivamurthy, S. A., & Shadakshari, S. (2025) · Journal of Water Process Engineering · doi:10.1016/j.jwpe.2025.109054 · Cited by 8
Antibiotics in the first hour: is there new evidence?
Dupuis, C., & Timsit, J. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1810567 · Cited by 7
Rapid diagnostics for skin and soft tissue infections: the current landscape and future potential
Barbier, F., Woerther, P., & Timsit, J. (2023) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000901 · Cited by 8
Waele, J. J. D., Leroux‐Roels, I., & Morris, A. C. (2024) · Intensive Care Medicine · doi:10.1007/s00134-024-07319-5 · Cited by 8
Bronchoscopic Diagnosis of Severe Respiratory Infections
Röder, M., Cordero, N. A. Y. K., & Morris, A. C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13196020 · Cited by 15
Martínez-Pérez, M., Fernández-Fernández, R., Morón, R., Nieto-Sánchez, M. T., Yuste, M. E., Díaz-Villamarín, X., Fernández-Varón, E., Blanquiño, A. V., Romano, A. A., Barrera, J. C., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216482 · Cited by 9
Jones, W. S., Suklan, J., Winter, A., Green, K., Craven, T., Bruce, A. M., Mair, J., Dhaliwal, K., Walsh, T. S., Simpson, A. J., et al. (2022) · Diagnostic and Prognostic Research · doi:10.1186/s41512-022-00117-x · Cited by 12
On Low-Value Nursing Care: Part 1, Why De-implementation Matters for Quality Care
Halm, M. A. (2022) · American Journal of Critical Care · doi:10.4037/ajcc2022857 · Cited by 8
Wang, Y., Gao, S., Xu, Y., Tang, Z., & Liu, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-30927-y · Cited by 8
Qader, I. B., Ganjo, A. R., Ahmad, H. O., Qader, H. A., & Hamadameen, H. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02739-4 · Cited by 7
Challenging management dogma where evidence is non-existent, weak, or outdated: part II
Hofmaenner, D. A., & Singer, M. (2024) · Intensive Care Medicine · doi:10.1007/s00134-024-07634-x · Cited by 7
Bai, Y., Hu, Y., Chen, X., Hu, L., Wu, K., Liang, S., Zheng, J., Gänzle, M. G., & Chen, C. (2025) · mSystems · doi:10.1128/msystems.01444-24 · Cited by 11
Ling, L., Wong, W., Lipman, J., & Joynt, G. M. (2022) · Antibiotics · doi:10.3390/antibiotics11040452 · Cited by 9
Self-citationNuutila, J., Hohenthal, U., Oksi, J., & Jalava‐Karvinen, P. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103724 · Cited by 7
Bay, P., Cappy, P., Rodriguez, C., Mongardon, N., Petit, M., Voiriot, G., Sonneville, R., de Chambrun, M. P., Urbina, T., Pham, T. O., et al. (2026) · Critical Care · doi:10.1186/s13054-025-05764-2 · Cited by 7
Rademacher, J., Ewig, S., Grabein, B., Nachtigall, I., Abele‐Horn, M., Deja, M., Gaßner, M., Gatermann, S. G., Geffers, C., Gerlach, H., et al. (2024) · Infection · doi:10.1007/s15010-024-02358-y · Cited by 7
Cibulková, I., Řehořová, V., Soukupova, H., Waldauf, P., Cahová, M., Maňák, J., Matějovič, M., & Duška, F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310180 · Cited by 8
Global personalization of antibiotic therapy in critically ill patients
Lonsdale, D., & Lipman, J. (2021) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2021.1874823 · Cited by 7
Self-citationWang, H., Li, B., Zhao, J., Tian, Y., & Qiu, Y. (2021) · Water · doi:10.3390/w13233398 · Cited by 6
Frattari, A., Polilli, E., Timelli, L., Spagnuolo, F., Fazii, P., & Parruti, G. (2024) · Antibiotics · doi:10.3390/antibiotics13111001 · Cited by 6
Scheer, C., Annane, D., Artigas, A., Linder, A., Sander, M., Demirkıran, O., Reinhart, K., & Giamarellos‐Bourboulis, E. J. (2025) · Critical Care · doi:10.1186/s13054-025-05582-6 · Cited by 9
Hu, R., Zhao, W., Chen, R., Zhao, S., Khan, A., Li, X., & Xu, A. (2024) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2024.114678 · Cited by 5
Kim, J. G., & Jun, J. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-10994-3 · Cited by 5
Wang, C., Zheng, H., Ma, R., Zheng, X.-C., & Guan, X. (2025) · Molecules · doi:10.3390/molecules30071417 · Cited by 4
Scheer, C., Giamarellos-Bourboulis, E. J., Annane, D., Artigas, A., Aslan, A. T., Bottari, G., Bouma, H. R., Černý, V., Radivojević, R. C., Dewitte, K., et al. (2025) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2025.101570 · Cited by 7
Physician Variation in Early Sepsis Management
Peltan, I. D., Groat, D., Butler, J., Bledsoe, J. R., Ofori-Atta, B. S., Wu, C., Presson, A. P., Greene, T. H., Christensen, M. A., Schroeder, F. M., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.56945 · Cited by 6
Řehořová, V., Cibulková, I., Soukupova, H., & Duška, F. (2022) · Future Pharmacology · doi:10.3390/futurepharmacol2010005 · Cited by 4
Rollas, K., Ersan, G., Emgin, Ö., Çalışkan, T., Yavuz, T., & Sarac, O. (2022) · Journal of Critical and Intensive Care · doi:10.37678/dcybd.2022.3156 · Cited by 4
Metadata
- Authors
- Arulkumaran, N., Routledge, M., Schlebusch, S., Lipman, J., & Conway Morris, A.
- Affiliations
- University College London (GB)
- University of Cambridge (GB)
- Queensland Health (AU)
- The University of Queensland (AU)
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2020-01-29
- Volume
- 46
- Issue
- 2
- Pages
- 225-235
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- PMC
- PMC7046486
- OpenAlex
- W3004103291
- Cited by
- 175
- References
- 103
- Citations by year
- 2026: 25 · 2025: 35 · 2024: 37 · 2023: 22 · 2022: 28 · 2021: 20 · 2020: 8
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (WT 2055214/Z/16/Z)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antimicrobial stewardship, intensive care, mitochondrial toxicity, adverse drug reactions, antimicrobial resistance, intensive care unit infections, harm mitigation
- MeSH terms
- Medical Overuse, Antimicrobial Stewardship, Anti-Infective Agents, Critical Care, Humans, Time Factors, Microbiota, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.